147 related articles for article (PubMed ID: 35394210)
1. Radiomics signature for the prediction of progression-free survival and radiotherapeutic benefits in pediatric medulloblastoma.
Liu ZM; Zhang H; Ge M; Hao XL; An X; Tian YJ
Childs Nerv Syst; 2022 Jun; 38(6):1085-1094. PubMed ID: 35394210
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI-Based Radiomics Signature with Machine Learning for Preoperative Prediction of Prognosis Stratification in Pediatric Medulloblastoma.
Luo Y; Zhuang Y; Zhang S; Wang J; Teng S; Zeng H
Acad Radiol; 2024 Apr; 31(4):1629-1642. PubMed ID: 37643930
[TBL] [Abstract][Full Text] [Related]
3. MRI Radiomics Signature of Pediatric Medulloblastoma Improves Risk Stratification Beyond Clinical and Conventional MR Imaging Features.
Zheng H; Li J; Liu H; Ting G; Yin Q; Li R; Liu M; Zhang Y; Duan S; Li Y; Wang D
J Magn Reson Imaging; 2023 Jul; 58(1):236-246. PubMed ID: 36412264
[TBL] [Abstract][Full Text] [Related]
4. Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
Zhang S; Song M; Zhao Y; Xu S; Sun Q; Zhai G; Liang D; Wu G; Li ZC
Eur J Radiol; 2020 Oct; 131():109219. PubMed ID: 32905953
[TBL] [Abstract][Full Text] [Related]
5. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
[TBL] [Abstract][Full Text] [Related]
6. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
7. A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas.
Liu X; Li Y; Qian Z; Sun Z; Xu K; Wang K; Liu S; Fan X; Li S; Zhang Z; Jiang T; Wang Y
Neuroimage Clin; 2018; 20():1070-1077. PubMed ID: 30366279
[TBL] [Abstract][Full Text] [Related]
8. A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation.
Fang S; Lai L; Zhu J; Zheng L; Xu Y; Chen W; Wu F; Wu X; Chen M; Weng Q; Ji J; Zhao Z; Tu J
Front Mol Biosci; 2021; 8():662366. PubMed ID: 34532340
[No Abstract] [Full Text] [Related]
9. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
[TBL] [Abstract][Full Text] [Related]
10. CT-based radiomics signature analysis for evaluation of response to induction chemotherapy and progression-free survival in locally advanced hypopharyngeal carcinoma.
Liu X; Long M; Sun C; Yang Y; Lin P; Shen Z; Xia S; Shen W
Eur Radiol; 2022 Nov; 32(11):7755-7766. PubMed ID: 35608663
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of thymomas: a combined radiomics nomogram to predict histologic subtypes.
Xiao G; Hu YC; Ren JL; Qin P; Han JC; Qu XY; Rong WC; Yan WQ; Tian Q; Han Y; Wang WP; Wang SM; Ma J; Wang W; Cui GB
Eur Radiol; 2021 Jan; 31(1):447-457. PubMed ID: 32700020
[TBL] [Abstract][Full Text] [Related]
12. A radiomics nomogram may improve the prediction of IDH genotype for astrocytoma before surgery.
Tan Y; Zhang ST; Wei JW; Dong D; Wang XC; Yang GQ; Tian J; Zhang H
Eur Radiol; 2019 Jul; 29(7):3325-3337. PubMed ID: 30972543
[TBL] [Abstract][Full Text] [Related]
13. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
[TBL] [Abstract][Full Text] [Related]
14. Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.
Zheng H; Li J; Liu H; Wu C; Gui T; Liu M; Zhang Y; Duan S; Li Y; Wang D
World J Surg Oncol; 2021 Apr; 19(1):134. PubMed ID: 33888125
[TBL] [Abstract][Full Text] [Related]
15. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract][Full Text] [Related]
17. A CT-based radiomics nomogram for predicting the progression-free survival in small cell lung cancer: a multicenter cohort study.
Zheng X; Liu K; Li C; Zhu C; Gao Y; Li J; Wu X
Radiol Med; 2023 Nov; 128(11):1386-1397. PubMed ID: 37597124
[TBL] [Abstract][Full Text] [Related]
18. Multi-institutional validation of a radiomics signature for identification of postoperative progression of soft tissue sarcoma.
Yu Y; Guo H; Zhang M; Hou F; Yang S; Huang C; Duan L; Wang H
Cancer Imaging; 2024 May; 24(1):59. PubMed ID: 38720384
[TBL] [Abstract][Full Text] [Related]
19. A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
Zhang W; Mao N; Wang Y; Xie H; Duan S; Zhang X; Wang B
Eur J Radiol; 2020 Jul; 128():109020. PubMed ID: 32371181
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric MRI-based radiomics nomogram for preoperative prediction of lymphovascular invasion and clinical outcomes in patients with breast invasive ductal carcinoma.
Zhang J; Wang G; Ren J; Yang Z; Li D; Cui Y; Yang X
Eur Radiol; 2022 Jun; 32(6):4079-4089. PubMed ID: 35050415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
